Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Phillip J Yates, PhD

GlaxoSmithKline, United Kingdom

Disclosure(s): GlaxoSmithKline: Employee

Poster(s):

304 - Viral resistance analysis in the COMET-PEAK study: sotrovimab treatment in participants with mild-to-moderate COVID-19
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET